REVLIMID Adverse Event: Plasma cell myeloma
REVLIMID Adverse Event: Plasma cell myeloma is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: REVLIMID; Product category: Drug; Primary reaction: Plasma cell myeloma.
| Primary drug | REVLIMID |
|---|---|
| Product category | Drug |
| Primary reaction | Plasma cell myeloma |
| All reactions | Plasma cell myeloma; Respiratory disorder; Arrhythmia |
| Seriousness | Serious |
| Patient outcome | Fatal |
| Patient sex | Male |
| All drugs reported | REVLIMID; REVLIMID; REVLIMID; REVLIMID |
| Reporter country | US |
| Reporter type | 2 |
| Report date | 20140312 |
| Report ID | 10003531 |
$299/mo
Try FDATracker →